tiprankstipranks
Eyepoint Pharma (DE:PV3B)
:PV3B
Germany Market

EyePoint Pharmaceuticals (PV3B) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Eyepoint Pharma’s (PV3B) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Eyepoint Pharma is a Buy.
Eyepoint Pharma’s (PV3B) 20-Day exponential moving average is 5.62, while Eyepoint Pharma’s (PV3B) share price is €5.16, making it a Sell.
Eyepoint Pharma’s (PV3B) 50-Day exponential moving average is 6.19, while Eyepoint Pharma’s (PV3B) share price is €5.16, making it a Sell.

EyePoint Pharmaceuticals (PV3B) Pivot Points

Apr 03, 2025, 07:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.78
4.97
5.06
5.25
5.35
5.54
5.63
Fibonacci
4.97
5.08
5.14
5.25
5.36
5.43
5.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

EyePoint Pharmaceuticals (PV3B) Moving Averages

Apr 03, 2025, 07:20 AM
Period
Simple
Exponential
MA5
5.33Sell
5.32Sell
MA10
5.40Sell
5.43Sell
MA20
5.66Sell
5.62Sell
MA50
6.25Sell
6.19Sell
MA100
7.23Sell
7.03Sell
MA200
7.83Sell
8.37Sell
Eyepoint Pharma’s (PV3B) 10-Day exponential moving average is 5.43, while Eyepoint Pharma’s (PV3B) share price is €5.16, making it a Sell.
Eyepoint Pharma’s (PV3B) 100-Day exponential moving average is 7.03, while Eyepoint Pharma’s (PV3B) share price is €5.16, making it a Sell.
Eyepoint Pharma’s (PV3B) stock price is €5.16 and Eyepoint Pharma’s (PV3B) 50-day simple moving average is 6.25, creating a Sell signal.
Eyepoint Pharma’s (PV3B) stock price is €5.16 and Eyepoint Pharma’s (PV3B) 100-day simple moving average is 7.23, creating a Sell signal.
Eyepoint Pharma’s (PV3B) stock price is €5.16 and Eyepoint Pharma’s (PV3B) 200-day simple moving average is 7.83, creating a Sell signal.

EyePoint Pharmaceuticals (PV3B) Technical Indicators

Apr 03, 2025, 07:20 AM
Name
Value
Implied Action
RSI (14)
40.74
Neutral
STOCH (9,6)
11.49
Buy
STOCHRSI (14)
5.17
Buy
MACD (12,26)
-0.26
Buy
ADX (14)
16.45
Buy
Williams %R
-92.05
Buy
CCI (14)
-108.72
Buy
ATR (14)
0.35
-
Ultimate Oscillator
24.86
Sell
ROC
-13.85
Sell
Eyepoint Pharma’s (PV3B) Relative Strength Index (RSI) is 40.74, creating a Neutral signal.
Eyepoint Pharma’s (PV3B) Trend Strength Indicator (ADX) is 16.45, creating a Buy signal.
Eyepoint Pharma’s (PV3B) Commodity Channel Index (CCI) is -108.72, creating a Buy signal.
Eyepoint Pharma’s (PV3B) Price Rate of Change (ROC) is -13.85, creating a Sell signal.

FAQ

Is PV3B a Buy, Hold, or Sell?
Based on PV3B’s technical indicators, PV3B is a Sell.
    What is PV3B’s RSI (14)?
    PV3B’s RSI (14) is 40.74, which suggests PV3B is a Neutral.
      What is PV3B’s MACD?
      PV3B’s MACD is -0.26, which suggests PV3B is a Buy.
        What is PV3B’s 5-day moving average?
        PV3B’s 5-day moving average is 5.33, which suggests PV3B is a Sell.
          What is PV3B’s 20-day moving average?
          PV3B 20-day moving average is 5.66, which suggests PV3B is a Sell.
            What is PV3B’s 50-day moving average?
            PV3B’s 50-day moving average is 6.25, which suggests PV3B is a Sell.
              What is PV3B’s 200-day moving average?
              PV3B’s 200-day moving average is 7.83, which suggests PV3B is a Sell.
                What is PV3B’s Williams % R (14)?
                PV3B’s Williams % R (14) is -92.05, which suggests PV3B is a Buy.
                  What is PV3B’s CCI (14)?
                  PV3B’s CCI (14) is -108.72, which suggests PV3B is a Buy.
                    What is the share price of Eyepoint Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis